CEFTAZIDIME 1 GM VIAL

What it is

CEFTAZIDIME 1 GM VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ceftazidime.

FDA gives its dosage form as injection, powder, for solution and its route as intramuscular; intravenous.

Its labelers, the companies named on the label, are Sagent Pharmaceuticals and WG Critical Care, LLC.

FDA’s Established Pharmacologic Class for it is Cephalosporin Antibacterial.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.70 for 1 unit (EA) (1 × $3.70448 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2025-12-17. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2025-12-17. The file is new; the price is not.

What NADAC measures · NADAC explanation codes · Carried-forward prices

All 2 NDCs

• 25021-0127-20 · Sagent Pharmaceuticals · $3.70448 per EA · eff. 2025-12-17 filed carried forward
• 44567-0235-25 · WG Critical Care, LLC · $3.70448 per EA · eff. 2025-12-17 filed carried forward

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $3.70448 per EA filed.

Of the 20 other products in FDA’s Cephalosporin Antibacterial class priced per EA, 2 have a higher middle NADAC price and 18 a lower one. The one in the middle is CEFPODOXIME 100 MG TABLET, at $1.0434 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part B’s payment limit for HCPCS J0713, for 2026-10-01 to 2026-12-31, comes to $3.10 for 1 unit (EA), or $3.098 per EA once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.3098 per 500 MG.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.